To test or not to test: The PSA and your prostate cancer risk

For men seeking clarity on whether to undergo routine prostate cancer screening, two recent studies in the Journal of the American Medical Association (JAMA) may raise new questions. Since 2012, there’s been a drop in the routine use of the blood test known as the PSA, short for prostate-specific antigen, according to the studies published on Nov. 17. Meanwhile, fewer prostate cancers are being diagnosed.